Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Land & Improvements (2022 - 2025)

Mesa Laboratories' Land & Improvements history spans 4 years, with the latest figure at $889000.0 for Q1 2025.

  • For Q1 2025, Land & Improvements changed 0.0% year-over-year to $889000.0; the TTM value through Mar 2025 reached $889000.0, changed 0.0%, while the annual FY2025 figure was $889000.0, 0.0% changed from the prior year.
  • Land & Improvements for Q1 2025 was $889000.0 at Mesa Laboratories, roughly flat from $889000.0 in the prior quarter.
  • Across five years, Land & Improvements topped out at $889000.0 in Q1 2022 and bottomed at $889000.0 in Q1 2022.
  • The 4-year median for Land & Improvements is $889000.0 (2022), against an average of $889000.0.
  • The largest YoY upside for Land & Improvements was 0.0% in 2023 against a maximum downside of 0.0% in 2023.
  • A 4-year view of Land & Improvements shows it stood at $889000.0 in 2022, then changed by 0.0% to $889000.0 in 2023, then changed by 0.0% to $889000.0 in 2024, then changed by 0.0% to $889000.0 in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Land & Improvements are $889000.0 (Q1 2025), $889000.0 (Q1 2024), and $889000.0 (Q1 2023).